1. Ma, Yanru, Zhang, Xinyu, Xuan, Baoqin, Chen, Haoyan, Hong, Jie. 2024. Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis. In Gut, 73, 268-281. doi:10.1136/gutjnl-2023-330009. https://pubmed.ncbi.nlm.nih.gov/37734910/
2. Rastad, Hadith, Samimisedeh, Parham, Alan, Mahin Seifi, Hashemnejad, Maryam, Alan, Mahnaz Seifi. 2022. The role of lncRNA CERS6-AS1 in cancer and its molecular mechanisms: A systematic review and meta-analysis. In Pathology, research and practice, 241, 154245. doi:10.1016/j.prp.2022.154245. https://pubmed.ncbi.nlm.nih.gov/36580796/
3. Suzuki, Motoshi, Cao, Ke, Kato, Seiichi, Tomida, Shuta, Takahashi, Takashi. 2020. CERS6 required for cell migration and metastasis in lung cancer. In Journal of cellular and molecular medicine, 24, 11949-11959. doi:10.1111/jcmm.15817. https://pubmed.ncbi.nlm.nih.gov/32902157/
4. Jeon, Sookyoung, Scorletti, Eleonora, Dempsey, Joseph, Bataller, Ramon, Carr, Rotonya M. 2023. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation. In Molecular metabolism, 78, 101804. doi:10.1016/j.molmet.2023.101804. https://pubmed.ncbi.nlm.nih.gov/37714377/
5. Yan, Kun, Hu, Chunyan, Liu, Chen, Ma, Shuyun, Li, Long. 2022. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2. In Histology and histopathology, 38, 823-835. doi:10.14670/HH-18-555. https://pubmed.ncbi.nlm.nih.gov/36444938/
6. Yu, Juan, Chen, Xiaoguang, Li, Jing, Wang, Furang. 2023. CERS6 antisense RNA 1 promotes colon cancer via upregulating mitochondrial calcium uniporter. In European journal of clinical investigation, 53, e13951. doi:10.1111/eci.13951. https://pubmed.ncbi.nlm.nih.gov/36628448/
7. Xiong, Shiyi, Song, Han. . LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p. In Annals of clinical and laboratory science, 53, 30-41. doi:. https://pubmed.ncbi.nlm.nih.gov/36889776/
8. Jindal, Udita, Mamgain, Mukesh, Nath, Uttam Kumar, Datta, Dipak, Jain, Neeraj. 2024. Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma. In Leukemia, 38, 2196-2209. doi:10.1038/s41375-024-02344-1. https://pubmed.ncbi.nlm.nih.gov/39003397/
9. Gao, Kan-Fei, Zhao, Yu-Fang, Liao, Wu-Jun, Xu, Guo-Li, Zhang, Jian-Dong. 2022. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis. In The Kaohsiung journal of medical sciences, 38, 542-553. doi:10.1002/kjm2.12522. https://pubmed.ncbi.nlm.nih.gov/35199935/
智鼠故事 
